Healthcare DIVE April 4, 2025
Rebecca Pifer

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his mind so the case could move forward, he said on Thursday.

Dive Brief:

  • Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against major pharmacy benefit managers, allowing the case to move forward and resuscitating a major challenge to the drug middlemen.
  • The FTC paused the litigation against CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx on Tuesday, saying it didn’t have enough commissioners to try the case after President Donald Trump fired two Democrats last month.
  • Ferguson and the other Republican commissioner, Melissa Holyoak, were both recused from the case. But...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
What’s going on with Walgreens?
RFK Jr. May Want To Ban Prescription Drug Ads, But Can He?
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
FTC pauses PBM litigation in win for Caremark, Express Scripts, Optum Rx
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation

Share This Article